0.28
Karyopharm Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
0.35
FY23:
0.23
FY24:
0.16
FY25:
0.10
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.03
FY22:
0.01
FY23:
0.01
FY24:
0.01
FY25:
0.01
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.31
FY22:
0.36
FY23:
0.24
FY24:
0.16
FY25:
0.11
Liabilities & Equity
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.07
FY22:
0.07
FY23:
0.07
FY24:
0.09
FY25:
0.09
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.31
FY22:
0.31
FY23:
0.31
FY24:
0.26
FY25:
0.31
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.08
FY22:
−0.02
FY23:
−0.14
FY24:
−0.19
FY25:
−0.29
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.31
FY22:
0.36
FY23:
0.24
FY24:
0.16
FY25:
0.11
All amounts in billions USD